OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND All milestones successfully met, including antibiotic stewardship module, mobile and cloud-based data access as well as comprehensive next generation sequencing resultsTriggers additional milestone...

OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND Triggers milestone payment of approximately $0.3 million ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company...

OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FIND Parties add several deliverables to initial R&D collaboration contractOverall potential revenue increased to up to euro 830 thousand ROCKVILLE, Md., April 05, 2023 (GLOBE NEWSWIRE) -- OpGen,...

Treasure & Shipwreck Recovery Announces Shipwreck Artifact Recovery, Plans to Secure Claim ST. PETERSBURG, Fla., Dec. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Treasure & Shipwreck Recovery, Inc. (“TSR” or “the Company”), currently trading on the OTC as BLIS, announces that it...

XY Findables Seeks Growth Capital; Starts Testing the Waters With Regulation A+ Under Title IV of the JOBS Act SAN DIEGO, April 26, 2016 (GLOBE NEWSWIRE) -- XY Findables™, known for their flagship product XY Find It, has launched a Regulation A+ equity crowdfunding initiative on StartEngine.com – an...